Content about Cardiovascular diseases

February 17, 2011

February is American Heart Month, and a professional group representing the country’s pharmacists is using that as an opportunity to encourage the public to learn how to prevent heart disease from the most easily accessible members of the healthcare system.

WASHINGTON — February is American Heart Month, and a professional group representing the country’s pharmacists is using that as an opportunity to encourage the public to learn how to prevent heart disease from the most easily accessible members of the healthcare system.

February 4, 2011

The cardiovascular drug market will turn into a difficult conquest in the years to come as it increasingly will be dominated by generics, but that isn’t stopping drug companies from continuing to develop treatments — 299 of them, according to a recent report by the Pharmaceutical Research and Manufacturers of America — for high cholesterol, hypertension, atrial fibrillation, heart failure and other heart-related conditions.

WHAT IT MEANS AND WHY IT'S IMPORTANT — The cardiovascular drug market will turn into a difficult conquest in the years to come as it increasingly will be dominated by generics, but that isn’t stopping drug companies from continuing to develop treatments — 299 of them, according to a recent report by the Pharmaceutical Research and Manufacturers of America — for high cholesterol, hypertension, atrial fibrillation, heart failure and other heart-related conditions.

February 1, 2011

Pharmacy and health policy advocates endlessly tout the cost-saving 
benefits of improved medication adherence. In January, CVS Caremark put more teeth into that argument with some dramatic new findings that should get the attention of every health plan payer.


January 6, 2011

Patients with one or more out of four chronic diseases studied who take their medications as prescribed may save the healthcare system as much as $7,800 per patient annually, according to findings of a new CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period.

WOONSOCKET, R.I. — Patients with one or more out of four chronic diseases studied who take their medications as prescribed may save the healthcare system as much as $7,800 per patient annually, according to findings of a new CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period.

November 22, 2010

Blood pressure monitor manufacturer Omron Healthcare is working with the American Heart Association to promote heart health ...

BANNOCKBURN, Ill. Blood pressure monitor manufacturer Omron Healthcare is working with the American Heart Association to promote heart health, Omron announced.

Under the partnership, Omron is supporting the AHA’s campaign to educate healthcare providers on treatments for high blood pressure, also known as hypertension, with the goal of reaching 50,000 providers by 2013.

November 21, 2010

A cholesterol-lowering drug made by Merck appears to reduce the risk of heart attacks, strokes...

DENVER A cholesterol-lowering drug made by Merck appears to reduce the risk of heart attacks, strokes and cardiac death in patients with chronic kidney disease, according to results of a new study.

 

Merck said results of a 9,000-patient clinical study showed that Vytorin (ezetimibe and simvastatin) reduced the risks by 16.1% compared with placebo. Results of the study were presented Saturday at the annual meeting of the American Society of Nephrology.

 

 

November 14, 2010

A drug made by Pfizer may help decrease the risk of cardiovascular death or heart...

CHICAGO — A drug made by Pfizer may help decrease the risk of cardiovascular death or heart failure hospitalization in patients with chronic heart failure, according to a late-stage clinical study.

The “Emphasis-HF” study — funded by Pfizer, published online in the New England Journal of Medicine and presented at the American Heart Association scientific sessions in Chicago — found that adding Inspra (eplerenone) to standard therapies reduced the risks compared with placebo.

October 6, 2010

Bayer Consumer Care and WomenHeart: The National Coalition for Women with Heart Disease on Wednesday...

September 27, 2010

The market for hypertension drugs will drop by $3 billion by the end of the...

BURLINGTON, Mass. The market for hypertension drugs will drop by $3 billion by the end of the decade due to generic competition, according to a new report by healthcare market research firm Decision Resources.

The report, announced Tuesday, found that the market for drugs to treat high blood pressure would decline from 2009’s $26 billion to $23 billion by 2019 in the United States, United Kingdom, France, Italy, Spain and Japan.

 

September 1, 2010

Omron Healthcare has joined forces with "The Dr. Oz Show" in an integrated media partnership...

BANNOCKBURN, Ill. Omron Healthcare has joined forces with "The Dr. Oz Show" in an integrated media partnership to help spread the word about the importance of home blood pressure monitoring, Omron announced Thursday.

 

May 24, 2010

A new study published in Circulation, the American Heart Association journal, found that cutting sugar-sweetened...

May 24, 2010

The use of at-home blood pressure monitors and Web-based reporting tools that connect clinicians and...

DENVER The use of at-home blood pressure monitors and Web-based reporting tools that connect clinicians and patients via the Internet appears to significantly improve patients’ ability to manage their high blood pressure to healthy levels, according to research from Kaiser Permanente released Friday.

May 5, 2010

A Forest Labs drug used to treat mild to moderate hypertension “significantly” reduced blood pressure...

May 2, 2010

A leading manufacturer and distributor of blood pressure monitors designed for home use announced a...

April 13, 2010

Take Care Health Systems has announced that it now is offering free blood pressure screenings...

CONSHOHOCKEN, Pa. Take Care Health Systems has announced that it now is offering free blood pressure screenings at all of its 359 Take Care Clinics nationwide through May 31.

March 14, 2010

Diabetes patients combining drugs to control blood fat and blood pressure may remain at risk...

NEW YORK Diabetes patients combining drugs to control blood fat and blood pressure may remain at risk for heart attacks and other heart disease, according to a study presented in Atlanta on Sunday.

February 10, 2010

The Food and Drug Administration has approved a drug by Daiichi Sankyo for treating hypertension...

February 9, 2010

A drug for treating a genetic cholesterol disorder decreased levels of “bad” LDL cholesterol in...

February 2, 2010

A new survey conducted by the University of Michigan Medical School revealed that diabetes patients...

January 24, 2010

Rite Aid on Monday announced that it again is supporting the American Heart Association’s "Go...

November 24, 2009

If anyone still doubted the extraordinary contributions that pharmacists can bring to the nation’s costly...

NEW YORK If anyone still doubted the extraordinary contributions that pharmacists can bring to the nation’s costly and overloaded healthcare system, the Nov. 23 issue of the Archives of Internal Medicine should lay their doubts to rest. In a report on a new and innovative approach to treating hypertension, the publication highlighted the impact that a true working collaboration between doctors and pharmacists can have on successful patient outcomes.